MedTrace Logo

Protection From Influenza: Determining the Impact of Prior Infection

NCT03004040 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-02-23

No results posted yet for this study

Summary

The investigators propose a unique methodology of studying infection and vaccination history and immune responses. As most studies in infection history are conducted on mice, limitations are inherent on their applicability to humans. A longitudinal comparison study following older adults (over the age of 65) hospitalized for influenza are followed through to their hospital discharge and vaccination in the following season. This will allow for the investigation of the course of infection, as well as impact on the response to vaccination.

Conditions

Interventions

BIOLOGICAL

Flu Vaccine

Sponsors & Collaborators

  • NOAMA NORTHERN ONTARIO ACADEMIC MEDICINE ASSOCIATION

    collaborator UNKNOWN

  • Health Sciences North Research Institute

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004040 on ClinicalTrials.gov